  0 Table of Contents |
  1 Home |
| 2 Libraries |
| 3 Measures |
| 4 Downloads |
 5 Artifacts Summary |
  5.1 Cesarean BirthFHIR |
  5.1.1 Library |
| 5.2 Hospital Harm – Falls with InjuryFHIR |
| 5.2.1 Library |
| 5.3 Severe Obstetric ComplicationsFHIR |
| 5.3.1 Library |
| 5.4 Discharged on Antithrombotic TherapyFHIR |
| 5.4.1 Library |
| 5.5 Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography in Adults - Clinician FHIR |
| 5.5.1 Library |
| 5.6 Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography in Adults - Facility IQR FHIR |
| 5.6.1 Library |
| 5.7 Venous Thromboembolism ProphylaxisFHIR |
| 5.7.1 Library |
| 5.8 Childhood Immunization StatusFHIR |
| 5.8.1 Library |
| 5.9 Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography in Adults - Facility OQR FHIR |
| 5.9.1 Library |
| 5.10 Hospital Harm - Postoperative Respiratory FailureFHIR |
| 5.10.1 Library |
| 5.11 Diabetes: Glycemic Status Assessment Greater Than 9%FHIR |
| 5.11.1 Library |
| 5.12 Emergency Care Access & Timeliness (HOQR)FHIR |
| 5.12.1 Library |
| 5.13 Cervical Cancer ScreeningFHIR |
| 5.13.1 Library |
| 5.14 Breast Cancer ScreeningFHIR |
| 5.14.1 Library |
| 5.15 Emergency Care Access & Timeliness (REHQR)FHIR |
| 5.15.1 Library |
| 5.16 Antidepressant Medication ManagementFHIR |
| 5.16.1 Library |
| 5.17 Colorectal Cancer ScreeningFHIR |
| 5.17.1 Library |
| 5.18 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract SurgeryFHIR |
| 5.18.1 Library |
| 5.19 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)FHIR |
| 5.19.1 Library |
| 5.20 Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes CareFHIR |
| 5.20.1 Library |
| 5.21 Primary Open-Angle Glaucoma (POAG): Optic Nerve EvaluationFHIR |
| 5.21.1 Library |
| 5.22 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)FHIR |
| 5.22.1 Library |
| 5.23 Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than or equal to 40%)FHIR |
| 5.23.1 Library |
| 5.24 Appropriate Testing for PharyngitisFHIR |
| 5.24.1 Library |
| 5.25 Dementia: Cognitive AssessmentFHIR |
| 5.25.1 Library |
| 5.26 Weight Assessment and Counseling for Nutrition and Physical Activity for Children/AdolescentsFHIR |
| 5.26.1 Library |
| 5.27 Depression Remission at Twelve MonthsFHIR |
| 5.27.1 Library |
| 5.28 Controlling High Blood PressureFHIR |
| 5.28.1 Library |
| 5.29 Intensive Care Unit Venous Thromboembolism ProphylaxisFHIR |
| 5.29.1 Library |
| 5.30 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up DocumentedFHIR |
| 5.30.1 Library |
| 5.31 Preventive Care and Screening: Screening for Depression and Follow-Up PlanFHIR |
| 5.31.1 Library |
| 5.32 HIV ScreeningFHIR |
| 5.32.1 Library |
| 5.33 Safe Use of Opioids - Concurrent PrescribingFHIR |
| 5.33.1 Library |
| 5.34 Closing the Referral Loop: Receipt of Specialist ReportFHIR |
| 5.34.1 Library |
| 5.35 Functional Status Assessment for Total Hip ReplacementFHIR |
| 5.35.1 Library |
| 5.36 Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation TherapyFHIR |
| 5.36.1 Library |
| 5.37 Intravesical Bacillus-Calmette-Guerin for Non-Muscle Invasive Bladder CancerFHIR |
| 5.37.1 Library |
| 5.38 Documentation of Current Medications in the Medical RecordFHIR |
| 5.38.1 Library |
| 5.39 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up PlanFHIR |
| 5.39.1 Library |
| 5.40 Anticoagulation Therapy for Atrial Fibrillation/FlutterFHIR |
| 5.40.1 Library |
| 5.41 Antithrombotic Therapy By End of Hospital Day 2FHIR |
| 5.41.1 Library |
| 5.42 Primary Caries Prevention Intervention as Offered by DentistsFHIR |
| 5.42.1 Library |
| 5.43 Children Who Have Dental Decay or CavitiesFHIR |
| 5.43.1 Library |
| 5.44 Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic HyperplasiaFHIR |
| 5.44.1 Library |
| 5.45 Hospital Harm - Severe HypoglycemiaFHIR |
| 5.45.1 Library |
| 5.46 Hospital Harm - Opioid-Related Adverse EventsFHIR |
| 5.46.1 Library |
| 5.47 Hospital Harm - Pressure InjuryFHIR |
| 5.47.1 Library |
| 5.48 Hospital Harm - Acute Kidney InjuryFHIR |
| 5.48.1 Library |
| 5.49 Hospital Harm - Severe HyperglycemiaFHIR |
| 5.49.1 Library |
| 5.50 Malnutrition Care ScoreFHIR |
| 5.50.1 Library |
| 5.51 Appropriate Treatment for ST-Segment Elevation Myocardial Infarction (STEMI) Patients in the Emergency Department FHIR |
| 5.51.1 Library |
| 5.52 Core Clinical Data Elements HW Mortality FHIR |
| 5.52.1 Library |
| 5.53 Oncology: Medical and Radiation Pain Intensity QuantifiedFHIR |
| 5.53.1 Library |
| 5.54 AHAOverall |
| 5.55 AdultOutpatientEncounters |
| 5.56 AdvancedIllnessandFrailty |
| 5.57 AlaraCommonFunctions |
| 5.58 Antibiotic |
| 5.59 CMS0334FHIRPCCesareanBirth |
| 5.60 CMS1017FHIRHHFI |
| 5.61 CMS1028FHIRPCSevereOBComps |
| 5.62 CMS104FHIRSTKDCAntithrombotic |
| 5.63 CMS1056CTClinicalFHIR |
| 5.64 CMS1074FHIRCTIQR |
| 5.65 CMS108FHIRVTEProphylaxis |
| 5.66 CMS117FHIRChildhoodImmunizationStatus |
| 5.67 CMS1206FHIRCTOQR |
| 5.68 CMS1218FHIRHHRF |
| 5.69 CMS122FHIRDiabetesAssessGreaterThan9Percent |
| 5.70 CMS1244FHIRECATHOQR |
| 5.71 CMS124FHIRCervicalCancerScreening |
| 5.72 CMS125FHIRBreastCancerScreening |
| 5.73 CMS1264FHIRECATREHQR |
| 5.74 CMS128FHIRAntidepressantMedManagement |
| 5.75 CMS130FHIRColorectalCancerScreening |
| 5.76 CMS133FHIRCataracts2040BCVAwithin90Days |
| 5.77 CMS135FHIRHFACEIorARBorARNIforLVSD |
| 5.78 CMS142FHIRDRCommunicationWithPhysicianManagingDiabetes |
| 5.79 CMS143FHIRPOAGOpticNerveEvaluation |
| 5.80 CMS144FHIRHFBetaBlockerTherapyforLVSD |
| 5.81 CMS145FHIRCADBetaBlockerTherapyPriorMIorLVSD |
| 5.82 CMS146FHIRAppropriateTestingforPharyngitis |
| 5.83 CMS149FHIRDementiaCognitiveAssessment |
| 5.84 CMS155FHIRWeightAssessandCounselforKids |
| 5.85 CMS159FHIRDepressionRemissionatTwelveMonths |
| 5.86 CMS165FHIRControllingHighBloodPressure |
| 5.87 CMS190VTEProphylaxisICUFHIR |
| 5.88 CMS22FHIRPCSBPScreeningFollowUp |
| 5.89 CMS2FHIRPCSDepressionScreenAndFollowUp |
| 5.90 CMS349FHIRHIVScreening |
| 5.91 CMS506FHIRSafeUseofOpioids |
| 5.92 CMS50FHIRCRLReceiptofSpecialistReport |
| 5.93 CMS56FHIRFunctionalStatusAssessmentforTotalHipReplacement |
| 5.94 CMS645FHIRBoneDensityProstateCancerAndrogenDeprivationTherapy |
| 5.95 CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
| 5.96 CMS68FHIRDocumentationofCurrentMedications |
| 5.97 CMS69FHIRPCSBMIScreenAndFollowUp |
| 5.98 CMS71FHIRSTKAnticoagAFFlutter |
| 5.99 CMS72FHIRSTKAntithromboticDay2 |
| 5.100 CMS74FHIRPrimaryCariesPreventionasOfferedbyDentists |
| 5.101 CMS75FHIRChildrenWhoHaveDentalDecayOrCavities |
| 5.102 CMS771FHIRUrinarySymptomScoreChangeBenignProstaticHyperplasia |
| 5.103 CMS816FHIRHHHypo |
| 5.104 CMS819FHIRHHORAE |
| 5.105 CMS826FHIRHHPI |
| 5.106 CMS832HHAKIFHIR |
| 5.107 CMS871HHHyperFHIR |
| 5.108 CMS986FHIRMalnutritionScore |
| 5.109 CMS996FHIRAptTxforSTEMI |
| 5.110 CMSFHIR844HybridHospitalWideMortality |
| 5.111 CQMCommon |
| 5.112 CumulativeMedicationDuration |
| 5.113 FHIRHelpers |
| 5.114 Hospice |
| 5.115 HospitalHarm |
| 5.116 eCQM Update QI Core 2025 |
| 5.117 eCQM Update QI Core 2025 |
| 5.118 eCQM Update QI Core 2025 |
| 5.119 eCQM Update QI Core 2025 |
| 5.120 OncologyPainIntensityQuantifiedFHIR |
| 5.121 PCMaternal |
| 5.122 PalliativeCare |
| 5.123 QICoreCommon |
| 5.124 Status |
| 5.125 SupplementalDataElements |
| 5.126 TJCOverall |
| 5.127 VTE |
